Poor improvement of on-treatment FIB-4 index after initiation of nucleos(t)ide analogs is associated with development of hepatocellular carcinoma in both cirrhotic and non-cirrhotic chronic hepatitis B patients.
Poor improvement of on-treatment FIB-4 index after initiation of nucleos(t)ide analogs is associated with development of hepatocellular carcinoma in both cirrhotic and non-cirrhotic chronic hepatitis B patients.
复制标题
开始使用核苷（酸）类似物后治疗中 FIB-4 指数改善不佳与肝硬化和非肝硬化慢性乙型肝炎患者发生肝细胞癌有关。
DOI：
--
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Mamoru Watanabe.
中科院分区：
文献类型：
--
作者：
Miyako Murakawa;Yasuhiro Asahina;Mina Nakagawa;Taro Shimizu;Eiko Takeichi;Jun Tsuchiya;Ayako Sato;Masato Miyoshi;Fukiko Kawai-Kitahata;Sayuri Nitta;Yasuhiro Itsui;Sei Kakinuma;Seishin Azuma;Mamoru Watanabe.
